A successful switch from guselkumab to tildrakizumab during the treatment of a patient with psoriasis vulgaris

被引:0
|
作者
Yatsuzuka, Kazuki [1 ]
Murakami, Masamoto [1 ]
机构
[1] Ehime Univ, Dept Dermatol, Grad Sch Med, Toon, Ehime 7910295, Japan
关键词
D O I
10.1002/cia2.12284
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:98 / 99
页数:2
相关论文
共 50 条
  • [31] The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris
    Nakao, Momoko
    Asano, Yoshihide
    Nakamura, Kouki
    Shida, Rino
    Takahashi, Takehiro
    Yoshizaki, Ayumi
    Mitsui, Aya
    Shibata, Sayaka
    Araki, Mayuko
    Watanabe, Rei
    Ikawa, Yuko
    Toyoda, Chizuko
    Oka, Hisayoshi
    Sato, Shinichi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (04) : 404 - 405
  • [32] Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib
    Ferrucci, Silvia Mariel
    Buffon, Stefano
    Marzano, Angelo Valerio
    Maronese, Carlo Alberto
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (05) : 986 - 987
  • [33] Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice
    Mansilla-Polo, Miguel
    Sahuquillo-Torralba, Antonio
    Pujol-Marco, Conrad
    Bargues-Navarro, Guillermo
    Botella-Estrada, Rafael
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (06) : 922 - 927
  • [34] No Increased Risk of Liver Dysfunction from Tildrakizumab Treatment: Post Hoc Analyses of the Tildrakizumab Psoriasis Clinical Program
    Lebwohl, Mark
    West, Darren
    Mendelsohn, Alan
    Rozzo, Stephen
    Girolomoni, Giampiero
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [35] Polymyositis and pemphigus vulgaris in a patient: Successful treatment with rituximab
    Tournadre, Anne
    Amarger, Stephanie
    Joly, Pascal
    d'Incan, Michel
    Ristori, Jean-Michel
    Soubrier, Martin
    JOINT BONE SPINE, 2008, 75 (06) : 728 - 729
  • [36] Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab
    Fukada, Norihito
    Suzuki, Tomohiro
    Aoyama, Kazuhiro
    Kinjo, Akihiko
    Yamazaki, Kazuto
    Sato, Tomotaka
    JOURNAL OF DERMATOLOGY, 2023, 50 (02): : e72 - e73
  • [37] LATE-ONSET NEUROFIBROMAS DEVELOPED IN A PATIENT WITH PSORIASIS-VULGARIS DURING PUVA TREATMENT
    NISHIMURA, M
    HORI, Y
    ARCHIVES OF DERMATOLOGY, 1990, 126 (04) : 541 - 542
  • [38] Successful treatment of nevoid psoriasis with Secukinumab in a pediatric patient
    Neema, Shekhar
    Mannu, Anand
    Vasudevan, Biju
    Bhatt, Siddharth
    Krishnan, Lekshmipriya
    Kashif, A. W.
    DERMATOLOGIC THERAPY, 2022, 35 (06)
  • [39] Successful treatment of subacute cutaneous lupus erythematosus with the TYK-2 inhibitor deucravacitinib in a patient with concomitant psoriasis vulgaris
    Assaf, Katharina
    Patt, Selina
    Schaefer, Valentin Sebastian
    Wenzel, Joerg
    Novak, Natalija
    Wilsmann-Theis, Dagmar
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025,
  • [40] Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris
    Yamaguchi, Keiko
    Hayashi, Takaaki
    Takahashi, Genichiro
    Momose, Mami
    Asahina, Akihiko
    Nakano, Tadashi
    CASE REPORTS IN OPHTHALMOLOGY, 2018, 9 (03): : 499 - 503